손장원 프로필 사진

손장원

Sohn, Jang Won

의과대학

내과학교실

Scopus ORCID

연구분야

  • 호흡기알레르기내과

자료 필터

자료유형

발행연도

1999 ~ 2026
1999 2026

키워드

언어

전체 395건 중 41번부터 50번까지의 결과를 표시합니다.

2022
Article

Chronic Obstructive Pulmonary Disease is Associated with a More Symptomatic Burden and Severe Presentation of COVID-19: A Korean National COVID-19 Cohort Study

  • 2022-03
  • Tohoku Journal of Experimental Medicine
  • TOHOKU UNIV MEDICAL PRESS
Article

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease

  • 2022-03
  • FRONTIERS IN MEDICINE
  • FRONTIERS MEDIA SA
Article

Female Reproductive Factors and Incidence of Nontuberculous Mycobacterial Pulmonary Disease Among Postmenopausal Women in Korea

  • 2022-02
  • Clinical Infectious Diseases
  • OXFORD UNIV PRESS INC
2021
Article

액상형 전자담배의 호흡기 건강 영향

  • 2021-12
  • Journal of Korean society for research on nicotine and tobacco
  • 대한금연학회
Article

Impact of latent tuberculosis treatment on the risk of mycobacterium tuberculosis (MTB) in seropositive rheumatoid arthritis initiating TNF inhibitors in an MTB endemic area

  • 2021-12
  • Rheumatology
  • OXFORD UNIV PRESS
Article

Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions

  • 2021-11
  • Frontiers in Immunology
  • FRONTIERS MEDIA SA
Article

Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study

  • 2021-11
  • Allergy, Asthma & Immunology Research
  • KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
Conference

SYNERGISTIC TOXICITY OF COPPER AND ISONIAZID CAUSE ISONIAZID-INDUCED HEPATOTOXICITY

  • 2021-10-14
  • 미국
Article

The usefulness of fef25–75 in predicting airway hyperresponsiveness to mannitol

  • 2021-10
  • Journal of Asthma and Allergy
  • Dove Medical Press Ltd
Article

Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2

  • 2021-09
  • Frontiers in Medicine
  • Frontiers Media S.A.